Bayer | Oncology’s Post

View organization page for Bayer | Oncology, graphic

7,641 followers

Results from a phase 3 clinical trial provide new insights into management of patients with mCRPC 🩺    Abstract: LBA1, Proffered Paper     Discover more: https://lnkd.in/eytECTz8

  • No alternative text description for this image
Anti Sainast

MD | Healthcare Leader | Expertise in Medical, Commercial & Market Access | Launch Excellence & Cross-functional Collaboration

2mo

Never underestimate great old, but unique product!

Great news for advanced metastatic prostate cancer patients. Highest OS of any study in mCRPC- truly awesome!

Jan Heybroek

Serial entrepreneur, commercialization expert. Driving innovation to growth and success. Clinical collaboration with curated AI; join our team in revolutionizing clinical care.

2mo

Great achievement and very meaningful for those patients suffering from mCRPC!

Like
Reply
Jerry Rosenblatt, Ph.D.

Managing Partner at Rosenblatt Life Science Consultants

2mo

Congrats to the team!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics